BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24637873)

  • 1. Renin inhibitor VTP-27999 differs from aliskiren: focus on their intracellular accumulation and the (pro)renin receptor.
    Lu X; Krop M; Batenburg WW; Musterd-Bhaggoe UM; Garrelds IM; Danser AH
    J Hypertens; 2014 Jun; 32(6):1255-63. PubMed ID: 24637873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New renin inhibitor VTP-27999 alters renin immunoreactivity and does not unfold prorenin.
    Krop M; Lu X; Verdonk K; Schalekamp MA; van Gool JM; McKeever BM; Gregg R; Danser AH
    Hypertension; 2013 May; 61(5):1075-82. PubMed ID: 23460288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells.
    Batenburg WW; de Bruin RJ; van Gool JM; Müller DN; Bader M; Nguyen G; Danser AH
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1151-7. PubMed ID: 18388329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin- and prorenin-induced effects in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor: does (pro)renin-(pro)renin receptor interaction actually occur?
    Batenburg WW; Lu X; Leijten F; Maschke U; Müller DN; Danser AH
    Hypertension; 2011 Dec; 58(6):1111-9. PubMed ID: 22025376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes.
    Sakoda M; Ichihara A; Kurauchi-Mito A; Narita T; Kinouchi K; Murohashi-Bokuda K; Saleem MA; Nishiyama A; Suzuki F; Itoh H
    Am J Hypertens; 2010 May; 23(5):575-80. PubMed ID: 20075844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren.
    Schefe JH; Neumann C; Goebel M; Danser J; Kirsch S; Gust R; Kintscher U; Unger T; Funke-Kaiser H
    J Hypertens; 2008 Sep; 26(9):1787-94. PubMed ID: 18698213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats.
    Feldman DL; Jin L; Xuan H; Contrepas A; Zhou Y; Webb RL; Mueller DN; Feldt S; Cumin F; Maniara W; Persohn E; Schuetz H; Jan Danser AH; Nguyen G
    Hypertension; 2008 Jul; 52(1):130-6. PubMed ID: 18490518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aliskiren accumulates in Renin secretory granules and binds plasma prorenin.
    Krop M; Garrelds IM; de Bruin RJ; van Gool JM; Fisher ND; Hollenberg NK; Jan Danser AH
    Hypertension; 2008 Dec; 52(6):1076-83. PubMed ID: 18981317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aliskiren binds to renin and prorenin bound to (pro)renin receptor in vitro.
    Biswas KB; Nabi AH; Arai Y; Nakagawa T; Ebihara A; Ichihara A; Watanabe T; Inagami T; Suzuki F
    Hypertens Res; 2010 Oct; 33(10):1053-9. PubMed ID: 20664543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximum renal responses to renin inhibition in healthy study participants: VTP-27999 versus aliskiren.
    Barkoudah E; van Thiel BS; Fisher ND; Gregg RA; Danser AH; Moukarbel GV; Hollenberg NK
    J Hypertens; 2016 May; 34(5):935-41. PubMed ID: 26882043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats.
    Batenburg WW; Verma A; Wang Y; Zhu P; van den Heuvel M; van Veghel R; Danser AH; Li Q
    PLoS One; 2014; 9(6):e100954. PubMed ID: 24968134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide.
    Feldt S; Batenburg WW; Mazak I; Maschke U; Wellner M; Kvakan H; Dechend R; Fiebeler A; Burckle C; Contrepas A; Jan Danser AH; Bader M; Nguyen G; Luft FC; Muller DN
    Hypertension; 2008 Mar; 51(3):682-8. PubMed ID: 18212269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do prorenin-synthesizing cells release active, 'open' prorenin?
    Martini AG; Krop M; Saleh L; Garrelds IM; Danser AH
    J Hypertens; 2017 Feb; 35(2):330-337. PubMed ID: 28005703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling.
    Feldt S; Maschke U; Dechend R; Luft FC; Muller DN
    J Am Soc Nephrol; 2008 Apr; 19(4):743-8. PubMed ID: 18235083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megalin: A Novel Endocytic Receptor for Prorenin and Renin.
    Sun Y; Goes Martini A; Janssen MJ; Garrelds IM; Masereeuw R; Lu X; Danser AHJ
    Hypertension; 2020 May; 75(5):1242-1250. PubMed ID: 32200675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aliskiren: the first direct renin inhibitor for hypertension.
    van den Meiracker AH; Jan Danser AH
    Curr Cardiol Rep; 2007 Nov; 9(6):470-6. PubMed ID: 17999872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine ovarian cells have (pro)renin receptors and prorenin induces resumption of meiosis in vitro.
    Dau AM; da Silva EP; da Rosa PR; Bastiani FT; Gutierrez K; Ilha GF; Comim FV; Gonçalves PB
    Peptides; 2016 Jul; 81():1-8. PubMed ID: 27060674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aliskiren reduces prorenin receptor expression and activity in cultured human aortic smooth muscle cells.
    Ferri N; Greco CM; Maiocchi G; Corsini A
    J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):469-74. PubMed ID: 21628356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the renin inhibitor aliskiren against retinal ischemia-reperfusion injury.
    Tenkumo K; Hirooka K; Sherajee SJ; Nakamura T; Itano T; Nitta E; Fujita T; Nishiyama A; Shiraga F
    Exp Eye Res; 2014 May; 122():110-8. PubMed ID: 24709336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct renin inhibitor ameliorates insulin resistance by improving insulin signaling and oxidative stress in the skeletal muscle from post-infarct heart failure in mice.
    Fukushima A; Kinugawa S; Takada S; Matsumoto J; Furihata T; Mizushima W; Tsuda M; Yokota T; Matsushima S; Okita K; Tsutsui H
    Eur J Pharmacol; 2016 May; 779():147-56. PubMed ID: 26988296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.